Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-ΚB

Breast Cancer Research

Volumn 13, Issue 5, 2011, Pages

  Wei, Li ^a,b   Liu, Tsung Ta ^a   Wang, Hsiu Huan ^c   Hong, Hui Mei ^c,d   Yu, Alice L ^e   Feng, Hsiang Pu ^c   Chang, Wen Wei ^c,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ENZYME ANTIBODY; HEAT SHOCK PROTEIN 27; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; QUERCETIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN; HSPB1 PROTEIN, HUMAN; HSPB2 PROTEIN, MOUSE; I KAPPA B KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER STEM CELL; CARCINOGENICITY; CELL MIGRATION; CELL NUCLEUS; CELL POPULATION; CONTROLLED STUDY; CYTOLOGY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BREAST TUMOR; DRUG EFFECT; DRUG SCREENING; FEMALE; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

ALDEHYDE DEHYDROGENASE; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HSP27 HEAT-SHOCK PROTEINS; HUMANS; I-KAPPA B KINASE; MICE; MICE, SCID; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASTIC STEM CELLS; NF-KAPPA B; PHOSPHORYLATION; QUERCETIN; RNA, SMALL INTERFERING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80054814409     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3042     Document Type: Article

References (35)

1. Georgopoulos C, Welch WJ: Role of the major heat shock proteins as molecular chaperones. Ann Rev Cell Biol. 1993, 9: 601-634. 10.1146/annurev.cb.09.110193.003125.
2. Soo ET, Yip GW, Lwin ZM, Kumar SD, Bay BH: Heat shock proteins as novel therapeutic targets in cancer. In Vivo. 2008, 22: 311-315.
3. Parcellier A, Schmitt E, Brunet M, Hammann A, Solary E, Garrido C: Small heat shock proteins HSP27 and alphaB-crystallin: cytoprotective and oncogenic functions. Antioxid Redox Sign. 2005, 7: 404-413. 10.1089/ars.2005.7.404.
4. O'Neill PA, Shaaban AM, West CR, Dodson A, Jarvis C, Moore P, Davies MP, Sibson DR, Foster CS: Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27. Br J Cancer. 2004, 90: 182-188. 10.1038/sj.bjc.6601449.
5. Mlynarczyk-Liszka J, Maksymiuk B, Ponikiewska D, Krzyzowska-Gruca S, Lange D, Krawczyk Z, Malusecka E: HSP27 diagnostic utility in the fine needle aspirate of breast. Correlation with progesterone and estrogen receptors. Neoplasma. 2009, 56: 357-360. 10.4149/neo_2009_04_357.
6. Kang SH, Kang KW, Kim KH, Kwon B, Kim SK, Lee HY, Kong SY, Lee ES, Jang SG, Yoo BC: Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability. BMC Cancer. 2008, 8: 286-10.1186/1471-2407-8-286.
7. Hansen RK, Parra I, Lemieux P, Oesterreich S, Hilsenbeck SG, Fuqua SA: Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells. Breast Cancer Res Treat. 1999, 56: 187-196.
8. Shin KD, Lee MY, Shin DS, Lee S, Son KH, Koh S, Paik YK, Kwon BM, Han DC: Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation. J Biol Chem. 2005, 280: 41439-41448. 10.1074/jbc.M507209200.
9. Dalerba P, Cho RW, Clarke MF: Cancer stem cells: models and concepts. Ann Rev Med. 2007, 58: 267-284. 10.1146/annurev.med.58.062105.204854.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003, 100: 3983-3988. 10.1073/pnas.0530291100.
11. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007, 1: 555-567. 10.1016/j.stem.2007.08.014.
12. Hsu HS, Lin JH, Huang WC, Hsu TW, Su K, Chiou SH, Tsai YT, Hung SC: Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27. Cancer. 2010, 117: 1516-1528.
13. Tang SN, Singh C, Nall D, Meeker D, Shankar S, Srivastava RK: The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J Mol Signal. 2010, 5: 14-10.1186/1750-2187-5-14.
14. Chang WW, Lee CH, Lee P, Lin J, Hsu CW, Hung JT, Lin JJ, Yu JC, Shao LE, Yu J, Wong CH, Yu AL: Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis. Proc Natl Acad Sci USA. 2008, 105: 11667-11672. 10.1073/pnas.0804979105.
15. ELDA: Limiting Dilution Analysis for stem cell research. [http://bioinf.wehi.edu.au/software/elda/]
16. Hansen RK, Oesterreich S, Lemieux P, Sarge KD, Fuqua SA: Quercetin inhibits heat shock protein induction but not heat shock factor DNA-binding in human breast carcinoma cells. Biochem Biophys Res Commun. 1997, 239: 851-856. 10.1006/bbrc.1997.7572.
17. Kim RJ, Kim SR, Roh KJ, Park SB, Park JR, Kang KS, Kong G, Tang B, Yang YA, Kohn EA, Wakefield LM, Nam JS: Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer. Cancer Lett. 2010, 287: 172-181. 10.1016/j.canlet.2009.06.010.
18. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008, 133: 704-715. 10.1016/j.cell.2008.03.027.
19. Parcellier A, Schmitt E, Gurbuxani S, Seigneurin-Berny D, Pance A, Chantome A, Plenchette S, Khochbin S, Solary E, Garrido C: HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol. 2003, 23: 5790-5802. 10.1128/MCB.23.16.5790-5802.2003.
20. Iliopoulos D, Hirsch HA, Struhl K: An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell. 2009, 139: 693-706. 10.1016/j.cell.2009.10.014.
21. Kostenko S, Moens U: Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci. 2009, 66: 3289-3307. 10.1007/s00018-009-0086-3.
22. Shin KD, Lee MY, Shin DS, Lee S, Son KH, Koh S, Paik YK, Kwon BM, Han DC: Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation. J Biol Chem. 2005, 280: 41439-41448. 10.1074/jbc.M507209200.
23. Bausero MA, Bharti A, Page DT, Perez KD, Eng JW, Ordonez SL, Asea EE, Jantschitsch C, Kindas-Mugge I, Ciocca D, Asea A: Sliencing the hsp25 gene eliminates migration capability of the highly metastatic murine 4T1 breast adenocarcinoma cell. Tumour Biol. 2006, 27: 17-26. 10.1159/000090152.
24. Somara S, Bitar KN: Tropomyosin interacts with phosphorylated HSP27 in agonist-induced contraction of smooth muscle. Am J Physiol Cell Physiol. 2004, 286: C1290-1301. 10.1152/ajpcell.00458.2003.
25. Didelot C, Schmitt E, Brunet M, Maingret L, Parcellier A, Garrido C: Heat shock proteins: endogenous modulators of apoptotic cell death. Handb Exp Pharmacol. 2006, 171-198.
26. Jego G, Hazoumé A, Seigneuric R, Garrido C: Targeting heat shock proteins in cancer. Cancer Lett. 2010
27. Arrigo AP, Simon S, Gibert B, Kretz-Remy C, Nivon M, Czekalla A, Guillet D, Moulin M, Diaz-Latoud C, Vicart P: Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. FEBS Lett. 2007, 581: 3665-3674. 10.1016/j.febslet.2007.04.033.
28. Arrigo AP: The cellular "networking" of mammalian Hsp27 and its functions in the control of protein folding, redox state and apoptosis. Adv Exp Med Biol. 2007, 594: 14-26. 10.1007/978-0-387-39975-1_2.
29. Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP, Pelicci PG: The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell. 2009, 138: 1083-1095. 10.1016/j.cell.2009.06.048.
30. Lagadec C, Vlashi E, Della Donna L, Meng Y, Dekmezian C, Kim K, Pajonk F: Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res. 2010, 12: R13-10.1186/bcr2479.
31. Knupfer H, Preiss R: Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res Treat. 2007, 102: 129-135. 10.1007/s10549-006-9328-3.
32. Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, Ceccarelli C, Santini D, Paterini P, Marcu KB, Chieco P, Bonafè M: IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest. 2007, 117: 3988-4002. 10.1172/JCI32533.
33. Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, Brown M, Wicinski J, Cabaud O, Charafe-Jauffret E, Birnbaum D, Guan JL, Dontu G, Wicha MS: CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest. 2010, 120: 485-497. 10.1172/JCI39397.
34. Wu MJ, Jan CI, Tsay YG, Yu YH, Huang CY, Lin SC, Liu CJ, Chen YS, Lo JF, Yu CC: Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol Cancer. 2010, 9: 283-10.1186/1476-4598-9-283.
35. Bausero MA, Page DT, Osinaga E, Asea A: Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumour Biol. 2004, 25: 243-251. 10.1159/000081387.